Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers

  • N. J. Birkbak
  • , Y. Li
  • , S. Pathania
  • , A. Greene-Colozzi
  • , M. Dreze
  • , C. Bowman-Colin
  • , Z. Sztupinszki
  • , M. Krzystanek
  • , M. Diossy
  • , N. Tung
  • , P. D. Ryan
  • , J. E. Garber
  • , D. P. Silver
  • , J. D. Iglehart
  • , Z. C. Wang
  • , D. Szuts
  • , Zoltan Szallasi
  • , A. L. Richardson

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)903-909
Number of pages7
JournalAnnals of Oncology
Volume29
Issue number4
DOIs
StatePublished - Apr 1 2018

ASJC Scopus Subject Areas

  • Hematology
  • Oncology

Keywords

  • Gene expression-based predictor of treatment sensitivity
  • Ovarian cancer
  • Platinum-based chemotherapy
  • Triple-negative breast cancer

Fingerprint

Dive into the research topics of 'Overexpression of BLM promotes DNA damage and increased sensitivity to platinum salts in triple-negative breast and serous ovarian cancers'. Together they form a unique fingerprint.

Cite this